Advertisement

Management of Severe Oral Inflammatory Conditions in Dogs and Cats

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Veterinary Clinics: Small Animal Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Arzi B.
        • Anderson J.G.
        • Verstraete F.J.
        Oral manifestations of systemic disorders in dogs and cats.
        J Vet Clin Sci. 2008; 1: 112-124
        • Anderson J.G.
        Approach to diagnosis of canine oral lesions.
        Compend Contin Educ. 1991; 13: 1215-1226
        • Anderson J.G.
        • Peralta S.
        • Kol A.
        • et al.
        Clinical and histopathologic characterization of canine chronic ulcerative stomatitis.
        Vet Pathol. 2017; 54: 511-519
        • Arzi B.
        • Clark K.C.
        • Sundaram A.
        • et al.
        Therapeutic efficacy of fresh, allogeneic mesenchymal stem cells for severe refractory feline chronic gingivostomatitis.
        Stem Cells Transl Med. 2017; 6: 1710-1722
        • Rodrigues M.X.
        • Bicalho R.C.
        • Fiani N.
        • et al.
        The subgingival microbial community of feline periodontitis and gingivostomatitis: characterization and comparison between diseased and healthy cats.
        Sci Rep. 2019; 9: 12340
        • Soukup J.W.
        • Bell C.M.
        The canine furcation cyst, a newly defined odontogenic cyst in dogs: 20 cases (2013-2017).
        J Am Vet Med Assoc. 2020; 256: 1359-1367
        • Anderson J.G.
        • Kol A.
        • Bizikova P.
        • et al.
        Immunopathogenesis of canine chronic ulcerative stomatitis.
        PLoS One. 2020; 15: e0227386
        • Vapniarsky N.
        • Simpson D.L.
        • Arzi B.
        • et al.
        Histological, immunological, and genetic analysis of feline chronic gingivostomatitis.
        Front Vet Sci. 2020; 7: 310
        • Anderson J.G.
        • Paster B.J.
        • Kokaras A.
        • et al.
        Characterization of the oral microbiome in canine chronic ulcerative stomatitis.
        J Immun Res. 2021; 7: 1037
        • Mandell G.L.
        Cytokines, phagocytes, and pentoxifylline.
        J Cardiovasc Pharmacol. 1995; 25: S20-S22
        • Thanhauser A.
        • Reiling N.
        • Bohle A.
        • et al.
        Pentoxifylline: a potent inhibitor of IL-2 and IFN-gamma biosynthesis and BCG-induced cytotoxicity.
        Immunology. 1993; 80: 151-156
        • Siegel A.N.
        • Rodrigues N.
        • Nasri F.
        • et al.
        Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment.
        Prog Neuropsychopharmacol Biol Psychiatry. 2021; 104: 110032
        • Thornhill M.H.
        • Baccaglini L.
        • Theaker E.
        • et al.
        A randomized, double-blind, placebo-controlled trial of pentoxifylline for the treatment of recurrent aphthous stomatitis.
        Arch Dermatol. 2007; 143: 463-470
        • Cavalcante R.C.
        • Tomasetti G.
        Pentoxifylline and tocopherol protocol to treat medication-related osteonecrosis of the jaw: A systematic literature review.
        J Craniomaxillofac Surg. 2020; 48: 1080-1086
        • Golub L.M.
        • Lee H.M.
        Periodontal therapeutics: Current host-modulation agents and future directions.
        Periodontol 2000. 2020; 82: 186-204
        • Hajishengallis G.
        • Chavakis T.
        • Lambris J.D.
        Current understanding of periodontal disease pathogenesis and targets for host-modulation therapy.
        Periodontol 2000. 2020; 84: 14-34
        • Griffin M.O.
        • Ceballos G.
        • Villarreal F.J.
        Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action.
        Pharmacol Res. 2011; 63: 102-107
        • Golub L.M.
        • Elburki M.S.
        • Walker C.
        • et al.
        Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases.
        Int Dent J. 2016; 66: 127-135
        • Kim S.E.
        • Hwang S.Y.
        • Jeong M.
        • et al.
        Clinical and microbiological effects of a subantimicrobial dose of oral doxycycline on periodontitis in dogs.
        Vet J. 2016; 208: 55-59
        • Kim S.E.
        • Kim S.
        • Jeong M.
        • et al.
        Experimental determination of a subantimicrobial dosage of doxycycline hyclate for treatment of periodontitis in Beagles.
        Am J Vet Res. 2013; 74: 130-135
        • Makarov M.V.
        • Trammell S.A.J.
        • Migaud M.E.
        The chemistry of the vitamin B3 metabolome.
        Biochem Soc Trans. 2019; 28: 131-147
        • Suzuki H.
        • Kunisawa J.
        Vitamin-mediated immune regulation in the development of inflammatory diseases.
        Endocr Metab Immune Disord Drug Targets. 2015; 15: 212-215
        • Bennett W.M.
        • Norman D.J.
        Action and toxicity of cyclosporine.
        Annu Rev Med. 1986; 37: 215-224
        • Archer T.M.
        • Boothe D.M.
        • Langston V.C.
        • et al.
        Oral cyclosporine treatment in dogs: a review of the literature.
        J Vet Intern Med. 2014; 28: 1-20
        • Kobayashi T.
        • Momoi Y.
        • Iwasaki T.
        Cyclosporine A inhibits the mRNA expressions of IL-2, IL-4 and IFN-gamma, but not TNF-alpha, in canine mononuclear cells.
        J Vet Med Sci. 2007; 69: 887-892
        • Matsuda S.
        • Koyasu S.
        Mechanisms of action of cyclosporine.
        Immunopharmacology. 2000; 47: 119-125
        • Zhang C.
        • Zhang J.
        • Yang B.
        • et al.
        Cyclosporin A inhibits the production of IL-17 by memory Th17 cells from healthy individuals and patients with rheumatoid arthritis.
        Cytokine. 2008; 42: 345-352
        • Pradhan S.
        • Madke B.
        • Kabra P.
        • et al.
        Anti-inflammatory and Immunomodulatory Effects of Antibiotics and Their Use in Dermatology.
        Indian J Dermatol. 2016; 61: 469-481
        • Arndt H.
        • Palitzsch K.D.
        • Grisham M.B.
        • et al.
        Metronidazole inhibits leukocyte-endothelial cell adhesion in rat mesenteric venules.
        Gastroenterology. 1994; 106: 1271-1276
        • Reitz M.
        • Rumpf M.
        • Knitza R.
        Metronidazole induces DNA strand-breaks in cultures of human lymphocytes and phytohemagglutinin-stimulated human lymphocytes.
        Arzneimittelforschung. 1991; 41: 65-69
        • Fararjeh M.
        • Mohammad M.K.
        • Bustanji Y.
        • et al.
        Evaluation of immunosuppression induced by metronidazole in Balb/c mice and human peripheral blood lymphocytes.
        Int Immunopharmacol. 2008; 8: 341-350
        • Tauro A.
        • Beltran E.
        • Cherubini G.B.
        • et al.
        Metronidazole-induced neurotoxicity in 26 dogs.
        Aust Vet J. 2018; 96: 495-501
        • Bredal W.P.
        • Gunnes G.
        • Vollset I.
        • et al.
        Oral eosinophilic granuloma in three cavalier King Charles spaniels.
        J Small Anim Pract. 1996; 37: 499-504
        • Madewell B.R.
        • Stannard A.A.
        • Pulley L.T.
        • et al.
        Oral eosinophilic granuloma in Siberian husky dogs.
        J Am Vet Med Assoc. 1980; 177: 701-703
        • Vercelli A.
        • Cornegliani L.
        • Portigliotti L.
        Eyelid eosinophilic granuloma in a Siberian husky.
        J Small Anim Pract. 2005; 46: 31-33
        • Mendelsohn D.
        • Lewis J.R.
        • Scott K.I.
        • et al.
        Clinicopathological features, risk factors and predispositions, and response to treatment of eosinophilic oral disease in 24 dogs (2000-2016).
        J Vet Dent. 2019; 36: 25-31
        • Singh B.B.
        • Baker R.
        • Boshell J.
        • et al.
        Observations on the eosinophilic granules in the dorsal papillae of the dog tongue.
        J Oral Pathol. 1980; 9: 99-105
        • Murphy B.
        • Bell C.M.
        • Soukup J.W.
        Veterinary oral and maxillofacial pathology. City and state.
        Wiley Blackwell, Hoboken (NJ)2020: 243
        • Huugen D.
        • van Esch A.
        • Xiao H.
        • et al.
        Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice.
        Kidney Int. 2007; 71: 646-654
        • Schreiber A.
        • Xiao H.
        • Jennette J.C.
        • et al.
        C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis.
        J Am Soc Nephrol. 2009; 20: 289-298
        • Zipfel P.F.
        • Wiech T.
        • Rudnick R.
        • et al.
        Complement Inhibitors in Clinical Trials for Glomerular Diseases.
        Front Immunol. 2019; 10: 2166
        • Carpenter S.
        • Tervaert J.W.
        • Yacyshyn E.
        Advances in therapeutic treatment options for ANCA-associated vasculitis.
        Expert Opin Orphan Drugs. 2020; 8: 127-136
        • Krug W.
        • Marretta S.M.
        • de Lorimier L.P.
        • et al.
        Diagnosis and management of Wegener's granulomatosis in a dog.
        J Vet Dent. 2006; 23: 231-236
        • Woodring T.
        • Abraham R.
        • Frisch S.
        A case of probable trimethoprim-sulfamethoxazole induced circulating antineutrophil cytoplasmic antibody-positive small vessel vasculitis.
        Dermatol Online J. 2017; 23 (13030/qt3j9537pg)
        • Phatak S.
        • Aggarwal A.
        • Agarwal V.
        • et al.
        Antineutrophil cytoplasmic antibody (ANCA) testing: Audit from a clinical immunology laboratory.
        Int J Rheum Dis. 2017; 20: 774-778
        • Savige J.
        • Trevisin M.
        • Pollock W.
        Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease.
        J Immunol Methods. 2018; 458: 1-7
        • Mutsaers A.J.
        Metronomic chemotherapy.
        Top Companion Anim Med. 2009; 24: 137-143
        • Matsuyama A.
        • Woods J.P.
        • Mutsaers A.J.
        Evaluation of toxicity of a chronic alternate day metronomic cyclophosphamide chemotherapy protocol in dogs with naturally occurring cancer.
        Can Vet J. 2017; 58: 51-55
        • Wingo K.
        Histopathologic diagnoses from biopsies of the oral cavity in 403 dogs and 73 cats [published correction appears in.
        J Vet Dent. 2018; 35 (2018;35:307): 7-17
        • Mikiewicz M.
        • Paździor-Czapula K.
        • Gesek M.
        • et al.
        Canine and feline oral cavity tumours and tumour-like lesions: a retrospective study of 486 cases (2015-2017).
        J Comp Pathol. 2019; 172: 80-87
        • Falcão F.
        • Faísca P.
        • Viegas I.
        • et al.
        Feline oral cavity lesions diagnosed by histopathology: a 6-year retrospective study in Portugal.
        J Feline Med Surg. 2020; 22: 977-983
        • Hennet P.R.
        • Camy G.A.
        • McGahie D.M.
        • et al.
        Comparative efficacy of a recombinant feline interferon omega in refractory cases of calicivirus-positive cats with caudal stomatitis: a randomised, multi-centre, controlled, double-blind study in 39 cats.
        J Feline Med Surg. 2011; 13: 577-587
        • Farcas N.
        • Lommer M.J.
        • Kass P.H.
        • et al.
        Dental radiographic findings in cats with chronic gingivostomatitis (2002-2012).
        J Am Vet Med Assoc. 2014; 244: 339-345
        • Jennings M.W.
        • Lewis J.R.
        • Soltero-Rivera M.M.
        • et al.
        Effect of tooth extraction on stomatitis in cats: 95 cases (2000-2013).
        J Am Vet Med Assoc. 2015; 246: 654-660
        • Winer J.N.
        • Arzi B.
        • Verstraete F.J.
        Therapeutic management of feline chronic gingivostomatitis: A systematic review of the literature.
        Front Vet Sci. 2016; 3: 54
        • Rolim V.M.
        • Pavarini S.P.
        • Campos F.S.
        • et al.
        Clinical, pathological, immunohistochemical and molecular characterization of feline chronic gingivostomatitis.
        J Feline Med Surg. 2017; 19: 403-409
        • Lee D.B.
        • Verstraete F.J.M.
        • Arzi B.
        An Update on Feline Chronic Gingivostomatitis.
        Vet Clin North Am Small Anim Pract. 2020; 50: 973-982
        • Hennet P.
        Chronic gingivo-stomatitis in cats: Long-term follow-up of 30 cases treated by dental extractions.
        J Vet Dent. 1997; 14: 15-21
        • Bellei E.
        • Dalla F.
        • Masetti L.
        • et al.
        Surgical therapy in chronic feline gingivostomatitis (FCGS).
        Vet Res Commun. 2008; 32: S231-S234
        • Dolieslager S.M.J.
        Studies on the aetiopathogenesis of feline chronic gingivostomatitis [PhD Thesis].
        University of Glasgow, Glasgow (Scotland)2013
        • Druet I.
        • Hennet P.
        Relationship between Feline calicivirus load, oral lesions, and outcome in feline chronic gingivostomatitis (caudal stomatitis): Retrospective study in 104 cats.
        Front Vet Sci. 2017; 4: 209
        • Harley R.
        • Gruffydd-Jones T.J.
        • Day M.J.
        Immunohistochemical characterization of oral mucosal lesions in cats with chronic gingivostomatitis.
        J Comp Pathol. 2011; 144: 239-250
        • Fried W.A.
        • Soltero-Rivera M.
        • Ramesh A.
        • et al.
        Use of unbiased metagenomic and transcriptomic analyses to investigate the association between feline calicivirus and feline chronic gingivostomatitis in domestic cats.
        Am J Vet Res. 2021; 82: 381-394
        • Lommer M.J.
        • Verstraete F.J.
        Concurrent oral shedding of feline calicivirus and feline herpesvirus 1 in cats with chronic gingivostomatitis.
        Oral Microbiol Immunol. 2003; 18: 131-134
        • Dowers K.L.
        • Hawley J.R.
        • Brewer M.M.
        • et al.
        Association of Bartonella species, feline calicivirus, and feline herpesvirus 1 infection with gingivostomatitis in cats.
        J Feline Med Surg. 2010; 12: 314-321
        • Quimby J.M.
        • Elston T.
        • Hawley J.
        • et al.
        Evaluation of the association of Bartonella species, feline herpesvirus 1, feline calicivirus, feline leukemia virus and feline immunodeficiency virus with chronic feline gingivostomatitis.
        J Feline Med Surg. 2008; 10: 66-72
        • Dolieslager S.M.
        • Riggio M.P.
        • Lennon A.
        • et al.
        Identification of bacteria associated with feline chronic gingivostomatitis using culture-dependent and culture-independent methods.
        Vet Microbiol. 2011; 148: 93-98
        • Krumbeck J.A.
        • Reiter A.M.
        • Pohl J.C.
        • et al.
        Characterization of oral microbiota in cats: Novel insights on the potential role of fungi in feline chronic gingivostomatitis.
        Pathogens. 2021; 10: 904
        • Povey C.
        Viral diseases of cats: Current concepts.
        Vet Rec. 1976; 98: 293-299
        • Gaskell R.M.
        • Gruffydd-Jones T.
        Intractable feline stomatitis.
        Vet Annu. 1977; 17: 195-199
        • Reubel G.H.
        • Hoffmann D.E.
        • Pedersen N.C.
        Acute and chronic faucitis of domestic cats. A feline calicivirus-induced disease.
        Vet Clin North Am Small Anim Pract. 1992; 22: 1347-1360
        • Peralta S.
        • Carney P.C.
        Feline chronic gingivostomatitis is more prevalent in shared households and its risk correlates with the number of cohabiting cats.
        J Feline Med Surg. 2019; 21: 1165-1171
        • Johnessee J.
        • Hurvitz A.
        Feline plasma cell gingivitis-pharyngitis.
        J Am Anim Hosp Assoc. 1983; 19: 179-181
        • White S.D.
        • Rosychuk R.A.
        • Janik T.A.
        • et al.
        Plasma cell stomatitis-pharyngitis in cats: 40 cases (1973-1991).
        J Am Vet Med Assoc. 1992; 200: 1377-1380
        • Harley R.
        • Helps C.R.
        • Harbour D.A.
        • et al.
        Cytokine mRNA expression in lesions in cats with chronic gingivostomatitis.
        Clin Diagn Lab Immunol. 1999; 6: 471-478
        • Hung Y.P.
        • Yang Y.P.
        • Wang H.C.
        • et al.
        Bovine lactoferrin and piroxicam as an adjunct treatment for lymphocytic-plasmacytic gingivitis stomatitis in cats.
        Vet J. 2014; 202: 76-82
        • Squarzoni P.
        • Bani D.
        • Cialdai F.
        • et al.
        NIR laser therapy in the management of feline stomatitis.
        SM Dermatolog J. 2017; 13: 1021
        • Arzi B.
        • Taechangam N.
        • Lommer M.J.
        • et al.
        Stem cell therapy prior to full-mouth tooth extraction lacks substantial clinical efficacy in cats affected by chronic gingivostomatitis.
        J Feline Med Surg. 2021; 23: 604-608
        • Watanabe R.
        • Doodnaught G.
        • Proulx C.
        • et al.
        A multidisciplinary study of pain in cats undergoing dental extractions: A prospective, blinded, clinical trial.
        PLoS One. 2019; 14: e0213195
        • Steagall P.V.
        • Monteiro-Steagall B.P.
        Multimodal analgesia for perioperative pain in three cats.
        J Feline Med Surg. 2013; 15: 737-743
        • Castejón-González A.C.
        • Reiter A.M.
        Locoregional anesthesia of the head.
        Vet Clin North Am Small Anim Pract. 2019; 49: 1041-1061
        • de Vries M.
        • Putter G.
        Perioperative anaesthetic care of the cat undergoing dental and oral procedures: key considerations.
        J Feline Med Surg. 2015; 17: 23-36
        • Evangelista M.C.
        • Benito J.
        • Monteiro B.P.
        • et al.
        Clinical applicability of the Feline Grimace Scale: real-time versus image scoring and the influence of sedation and surgery.
        Peer J. 2020; 8: e8967
        • Watanabe R.
        • Doodnaught G.M.
        • Evangelista M.C.
        • et al.
        Inter-rater reliability of the Feline Grimace Scale in cats undergoing dental extractions.
        Front Vet Sci. 2020; 7: 302
        • Stathopoulou T.R.
        • Kouki M.
        • Pypendop B.H.
        • et al.
        Evaluation of analgesic effect and absorption of buprenorphine after buccal administration in cats with oral disease.
        J Feline Med Surg. 2018; 20: 704-710
        • Gulledge B.M.
        • Messenger K.M.
        • Cornell K.K.
        • et al.
        Pharmacokinetic comparison of two buprenorphine formulations after buccal administration in healthy male cats.
        J Feline Med Surg. 2018; 20: 312-318
        • Watanabe R.
        • Marcoux J.
        • Evangelista M.C.
        • et al.
        The analgesic effects of buprenorphine (Vetergesic or Simbadol) in cats undergoing dental extractions: A randomized, blinded, clinical trial.
        PLoS One. 2020; 15: e0230079
        • Older C.E.
        • Gomes M.O.S.
        • Hoffmann A.R.
        • et al.
        Influence of the FIV status and chronic gingivitis on feline oral microbiota.
        Pathogens. 2020; 9: 383
        • Murison P.J.
        • Tacke S.
        • Wondratschek C.
        • et al.
        Postoperative analgesic efficacy of meloxicam compared to tolfenamic acid in cats undergoing orthopaedic surgery.
        J Small Anim Pract. 2010; 51: 526-532
        • Speranza C.
        • Schmid V.
        • Giraudel J.M.
        • et al.
        Robenacoxib versus meloxicam for the control of peri-operative pain and inflammation associated with orthopaedic surgery in cats: a randomised clinical trial.
        BMC Vet Res. 2015; 11: 79
        • Kongara K.
        • Cave N.
        • Weidgraaf K.
        • et al.
        Effect of non-steroidal anti-inflammatory drugs on glomerular filtration rate and urinary N-acetyl-β-D-glucosaminidase activity in cats after dental surgery.
        Vet Anaesth Analg. 2020; 47: 631-636
        • KuKanich K.
        • George C.
        • Roush J.K.
        • et al.
        Effects of low-dose meloxicam in cats with chronic kidney disease.
        J Feline Med Surg. 2021; 23: 138-148
        • Monteiro B.
        • Steagall P.V.M.
        • Lascelles B.D.X.
        • et al.
        Long-term use of non-steroidal anti-inflammatory drugs in cats with chronic kidney disease: from controversy to optimism.
        J Small Anim Pract. 2019; 60: 459-462
        • Lommer M.J.
        Efficacy of cyclosporine for chronic, refractory stomatitis in cats: A randomized, placebo-controlled, double-blinded clinical study.
        J Vet Dent. 2013; 30: 8-17
        • Arzi B.
        • Peralta S.
        • Fiani N.
        • et al.
        A multicenter experience using adipose-derived mesenchymal stem cell therapy for cats with chronic, non-responsive gingivostomatitis.
        Stem Cell Res Ther. 2020; 11: 115
        • Leal R.O.
        • Gil S.
        The use of recombinant feline interferon omega therapy as an immune-modulator in cats naturally infected with feline immunodeficiency virus: New perspectives.
        Vet Sci. 2016; 3: 32
        • Li S.F.
        • Zhao F.R.
        • Shao J.J.
        • et al.
        Interferon-omega: Current status in clinical applications.
        Int Immunopharmacol. 2017; 52: 253-260
        • Yamamoto J.K.
        • Okuda T.
        • Yanai A.
        Antifeline herpesvirus and calicivirus effects of feline interferon.
        J Interfer Res. 1990; 10: S114
        • Ueda Y.
        • Sakurai T.
        • Kasama K.
        • et al.
        Pharmacokinetic properties of recombinant feline interferon and its stimulatory effect on 2’,5’ oligoadenylate synthetase activity in the cat.
        J Vet Med Sci. 1993; 55: 1-6
        • Gomez-Lucia E.
        • Collado V.M.
        • Miró G.
        • et al.
        Follow-up of viral parameters in FeLV- or FIV-naturally infected cats treated orally with low doses of human interferon alpha.
        Viruses. 2019; 11: 845
        • Zeidner N.S.
        • Myles M.H.
        • Mathiason-DuBard C.K.
        • et al.
        Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome.
        Antimicrob Agents Chemoth. 1990; 34: 1749-1756
        • Cummins J.M.
        • Krakowka S.
        • Thompson C.D.
        Systemic effects of interferons after oral administration in animals and humans.
        Am J Vet Res. 2005; 66: 164-176
        • Tovey M.
        • Maury C.
        Oromucosal interferon therapy: marked antiviral and antitumor activity.
        J Interferon Cytokines Res. 1999; 19: 145-155
        • Leal R.O.
        • Gil S.
        • Brito M.T.
        • et al.
        The use of oral recombinant feline interferon omega in two cats with type II diabetes mellitus and concurrent feline chronic gingivostomatitis syndrome.
        Ir Vet J. 2013; 66: 19
        • Matsumoto H.
        • Teshima T.
        • Iizuka Y.
        • et al.
        Evaluation of the efficacy of the subcutaneous low recombinant feline interferon-omega administration protocol for feline chronic gingivitis-stomatitis in feline calicivirus-positive cats.
        Res Vet Sci. 2018; 121: 53-58
        • Colombo S.
        • Sartori R.
        Ciclosporin and the cat: Current understanding and review of clinical use.
        J Feline Med Surg. 2018; 20: 244-255
        • Cridge H.
        • Kordon A.
        • Pinchuk L.M.
        • et al.
        Effects of cyclosporine on feline lymphocytes activated in vitro.
        Vet Immunol Immunopathol. 2020; 219: 109962
        • Clark K.C.
        • Fierro F.A.
        • Ko E.M.
        • et al.
        Human and feline adipose-derived mesenchymal stem cells have comparable phenotype, immunomodulatory functions, and transcriptome.
        Stem Cell Res Ther. 2017; 8: 69
        • Dias I.E.
        • Pinto P.O.
        • Barros L.C.
        • et al.
        Mesenchymal stem cells therapy in companion animals: useful for immune-mediated diseases?.
        BMC Vet Res. 2019; 15: 358
        • Taechangam N.
        • Iyer S.S.
        • Walker N.J.
        • et al.
        Mechanisms utilized by feline adipose-derived mesenchymal stem cells to inhibit T lymphocyte proliferation.
        Stem Cell Res Ther. 2019; 10: 188
        • Arzi B.
        • Kol A.
        • Murphy B.
        • et al.
        Feline foamy virus adversely affects feline mesenchymal stem cell culture and expansion: implications for animal model development.
        Stem Cells Dev. 2015; 24: 814-823
        • Power H.T.
        • Ihrke P.J.
        Selected feline eosinophilic skin diseases.
        Vet Clin North Am Small Anim Pract. 1995; 25: 833-850
        • Bloom P.B.
        Canine and feline eosinophilic skin diseases.
        Vet Clin North Am Small Anim Pract. 2006; 36: 141-vii
        • Wildermuth B.E.
        • Griffin C.E.
        • Rosenkrantz W.S.
        Response of feline eosinophilic plaques and lip ulcers to amoxicillin trihydrate-clavulanate potassium therapy: a randomized, double-blind placebo-controlled prospective study.
        Vet Dermatol. 2012; 23 (e25): 110
        • Noli C.
        Flea biology, allergy and control.
        in: Noli C. Colombo S. Feline dermatology. Springer, Cham2020: 437-449
        • Ganz E.C.
        • Griffin C.E.
        • Keys D.A.
        • et al.
        Evaluation of methylprednisolone and triamcinolone for the induction and maintenance treatment of pruritus in allergic cats: a double-blinded, randomized, prospective study.
        Vet Dermatol. 2012; 23 (e72): 387
        • Buckley L.
        • Nuttall T.
        Feline eosinophilic granuloma complex(ities): some clinical clarification.
        J Feline Med Surg. 2012; 14: 471-481
        • Palmeiro B.S.
        Cyclosporine in veterinary dermatology.
        Vet Clin North Am Small Anim Pract. 2013; 43: 153-171
        • Heinrich N.A.
        • McKeever P.J.
        • Eisenschenk M.C.
        Adverse events in 50 cats with allergic dermatitis receiving ciclosporin.
        Vet Dermatol. 2011; 22: 511-520
        • Roberts E.S.
        • Tapp T.
        • Trimmer A.
        • et al.
        Clinical efficacy and safety following dose tapering of ciclosporin in cats with hypersensitivity dermatitis.
        J Feline Med Surg. 2016; 18: 898-905
        • Riehl J.
        • Bell C.M.
        • Constantaras M.E.
        • et al.
        Clinicopathologic characterization of oral pyogenic granuloma in 8 cats.
        J Vet Dent. 2014; 31: 80-86
        • Gracis M.
        • Molinari E.
        • Ferro S.
        Caudal mucogingival lesions secondary to traumatic dental occlusion in 27 cats: macroscopic and microscopic description, treatment and follow-up.
        J Feline Med Surg. 2015; 17: 318-328
        • Jafarzadeh H.
        • Sanatkhani M.
        • Mohtasham N.
        Oral pyogenic granuloma: a review.
        J Oral Sci. 2006; 48: 167-175
        • Kamal R.
        • Dahiya P.
        • Puri A.
        Oral pyogenic granuloma: various concepts of etiopathogenesis.
        J Oral Maxillofac Pathol. 2012; 16: 79-82
        • Tham H.L.
        • Linder K.E.
        • Olivry T.
        Deep pemphigus (pemphigus vulgaris, pemphigus vegetans and paraneoplastic pemphigus) in dogs, cats and horses: a comprehensive review.
        BMC Vet Res. 2020; 16: 457
        • Scott D.W.
        • Walton D.K.
        • Slater M.R.
        • et al.
        Immune-mediated dermatoses in domestic animals - 10 years after part 1.
        Comp Cont Educ Pract. 1987; 9: 424-551
        • Olivry T.
        • Jackson H.A.
        Diagnosing new autoimmune blistering skin diseases of dogs and cats.
        Clin Tech Small Anim Pract. 2001; 16: 225-229
        • Olivry T.
        • Chan L.S.
        • Xu L.
        • et al.
        Novel feline autoimmune blistering disease resembling bullous pemphigoid in humans: IgG autoantibodies target the NC16A ectodomain of type XVII collagen (BP180/BPAG2).
        Vet Pathol. 1999; 36: 328-335
        • Olivry T.
        • Dunston S.M.
        • Zhang G.
        • et al.
        Laminin-5 is targeted by autoantibodies in feline mucous membrane (cicatricial) pemphigoid.
        Vet Immunol Immunopathol. 2002; 88: 123-129
        • Buonavoglia A.
        • Leone P.
        • Dammacco R.
        • et al.
        Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy.
        Autoimmun Rev. 2019; 18: 349-358